Epstein–Barr Virus Driven Hodgkin’s Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma

Figure 1

(a, b) Cellular bone marrow with scattered large mononuclear and binuclear cells in an inflammatory background on H & E. (c) CD30 highlighting the Hodgkin’s cells. (d) EBER-ISH positive cells (blue chromogen).

(a)

(b)

(c)

(d)